Northpond Ventures
Tinashe Nyanhete, Ph.D., currently serves as an Associate at Northpond Ventures, following a tenure as a Consultant at Boston Consulting Group where results were delivered across the biopharma value chain. Previous roles include a Technology Transfer Fellow at Duke's Office for Translation & Commercialization, focusing on scientific and commercial due diligence of therapeutic assets, and research assistant positions at The National Institutes of Health and Stanford University, concentrating on HIV vaccine design, immune-oncology, and developmental biology. Tinashe Nyanhete has also contributed as a Policy Researcher at the University of Copenhagen, focusing on the integration of immigrants and refugees. Educationally, Tinashe Nyanhete earned a Ph.D. in Immunology from Duke University and a BA in Molecular Biology and Geography from Colgate University, complemented by an Advanced Level Certificate from Nyanga High School Marist Brothers.
This person is not in any offices
Northpond Ventures
Northpond Ventures is a leading global science, medical, and technology-driven venture firm dedicated to building and empowering breakthrough companies in life sciences and technology. Northpond has in excess of $1 billion of committed capital, with over 21 businesses represented in its portfolio. The firm’s investments target the greatest scientists, innovators, and entrepreneurs in life sciences, diagnostics, AI and machine learning, therapeutics, and affiliated sectors. Northpond has become among the most active investors in the life sciences and molecular diagnostics industries.